Medical Condition News

RSS

Researchers establish the first international criteria for standardized imaging of gliomas

Diffuse gliomas are malignant brain tumors and cannot be optimally examined by conventional imaging using MRI. Amino acid PET can better visualize the activity and spread of gliomas.

3 Jan 2024

Rare immune cell holds key to predicting melanoma treatment success

A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King's College London, Guy's and St Thomas' Hospital Trust, and the Francis Crick Institute have found.

3 Jan 2024

Patients with HPV-related head and neck cancers treated in community centers less likely to survive

Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less likely to survive, according to new research by investigators from the Johns Hopkins Kimmel Cancer Center and its Head and Neck Cancer Center.

3 Jan 2024

Yale scientists identify drug target that may alleviate joint degeneration in osteoarthritis

Yale researchers have identified a drug target that may alleviate joint degeneration associated with osteoarthritis, a debilitating condition that afflicts as many as 30 million people in the United States alone, which they report on Jan. 3 in the journal Nature.

3 Jan 2024

Brain's immune cells may be a key target for preventing cognitive deficits after radiation exposure

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester find that microglia - the brain's immune cells - can trigger cognitive deficits after radiation exposure and may be a key target for preventing these symptoms.

3 Jan 2024

$4.9 million grant awarded to build EndO-trial consortium for improving the lives of Crohn's patients

Cleveland Clinic and the University of Western Ontario have been awarded a $4.9 million grant from Helmsley Charitable Trust to build a consortium to develop clinical trial outcome tools for patients with Crohn's disease and permanent ileostomy.

3 Jan 2024

Existing beta blocker investigated as novel sickle cell therapy

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.

3 Jan 2024

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity.

3 Jan 2024

New standardized criteria for diagnosing brain tumors with amino acid PET

Diffuse gliomas are malignant brain tumors that cannot be optimally examined by means of conventional MRI imaging. So-called amino acid PET scans are better able to image the activity and spread of gliomas.

3 Jan 2024

Patients with narcolepsy face a dual nightmare of medication shortages and stigma

Nina Shand couldn't stay awake. She had taken afternoon naps since she was a teenager to accommodate her "work hard, play hard" attitude, but when she was in her mid-20s the sleepiness became more severe.

3 Jan 2024

Living alone? Adopting a pet might help slow cognitive decline among older adults

Researchers investigated the association between pet ownership and cognitive decline in the elderly.

3 Jan 2024

Dutch study finds that abstaining from caffeine can increase sleep disturbances in older women

Whether coffee consumption was associated with low sleep quality.

3 Jan 2024

Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these symptoms in animal models of the disease.

2 Jan 2024

Scientists link growth hormone to anxiety and fear memory through specific neuron group

Growth hormone (GH) acts on many tissues throughout the body, helping build bones and muscles, among other functions.

2 Jan 2024

Previously unidentified protein variant shields against Parkinson's disease

A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson's disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.

2 Jan 2024

New AI tool spotlights hidden cancers for better diagnosis

A new artificial intelligence tool that interprets medical images with unprecedented clarity does so in a way that could allow time-strapped clinicians to dedicate their attention to critical aspects of disease diagnosis and image interpretation.

2 Jan 2024

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

PET imaging with 68Ga-FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to new research published in the December issue of The Journal of Nuclear Medicine.

2 Jan 2024

Novel PET tracer accurately detects common cancer mutation for tailored treatment

A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy.

2 Jan 2024

Brain receptor discovery opens door to new therapies for addiction and mental health

Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric disorders.

2 Jan 2024

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

2 Jan 2024

Medical Condition News

Researchers establish the first international criteria for standardized imaging of gliomas

Rare immune cell holds key to predicting melanoma treatment success

Patients with HPV-related head and neck cancers treated in community centers less likely to survive

Yale scientists identify drug target that may alleviate joint degeneration in osteoarthritis

Brain's immune cells may be a key target for preventing cognitive deficits after radiation exposure

$4.9 million grant awarded to build EndO-trial consortium for improving the lives of Crohn's patients

Existing beta blocker investigated as novel sickle cell therapy

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

New standardized criteria for diagnosing brain tumors with amino acid PET

Patients with narcolepsy face a dual nightmare of medication shortages and stigma

Living alone? Adopting a pet might help slow cognitive decline among older adults

Dutch study finds that abstaining from caffeine can increase sleep disturbances in older women

Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1

Scientists link growth hormone to anxiety and fear memory through specific neuron group

Previously unidentified protein variant shields against Parkinson's disease

New AI tool spotlights hidden cancers for better diagnosis

68Ga-FAPI PET imaging superior to existing methods for detecting pancreatic cancer

Novel PET tracer accurately detects common cancer mutation for tailored treatment

Brain receptor discovery opens door to new therapies for addiction and mental health

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News